-Helius Medical Technologies Inc. Reports Third Quarter of Fiscal Year 2020 Financial Results
Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX: HSM) ('Helius' or the 'Company'), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended September 30, 2020.
Third Quarter and Recent Business Updates
The Company made a leadership change by appointing Dane C. Andreeff to the position of Interim President and Chief Executive Officer ('CEO'), and Blane Walter as Chairman of the Board of Directors. These moves followed the...